Top Markets
Coin of the day
BioNexus Gene Lab Corp. BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp.

BGLC
Classement en actions #35594
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala... BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Prix de l'action
$1.50
Dernière synchronisation: 2026-09-21
Capitalisation boursière
$3.63M
Changement (1 jour)
-4.46%
Changement (1 an)
-72.68%
Pays
MY
Échange BioNexus Gene Lab Corp. (BGLC)

Catégorie

Ratio P/S pour BioNexus Gene Lab Corp. (BGLC)
Ratio P/S au September 2026 TTM : 1.16
Selon les derniers rapports financiers et le cours de l'action de BioNexus Gene Lab Corp., le ratio cours/ventes actuel (TTM) est 1.16. À la fin de 2023, le ratio P/S était de 0.93.
Historique du ratio P/S pour BioNexus Gene Lab Corp. de 2016 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
2026 (TTM) 1.16 123.02%
2024 0.52 -43.84%
2023 0.93 -93.79%
2022 15.03 -44.95%
2021 27.30 37.30%
2020 19.89 -98.67%
2019 1.50K 117.75%
2018 687.59 -54.92%
2017 1.53K 0.00%
2016 0.00 0.00%
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
3.20 175.99%
US
6.48 459.13%
US
- -
US
0.66 -43.43%
US
- -
US